Antiphospholipid Syndrome
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
99
|
17
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Polyendocrinopathies, Autoimmune
|
group |
Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
166
|
21
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Sicca Syndrome
|
disease |
Eye Diseases; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases; Stomatognathic Diseases
|
Disease or Syndrome
|
132
|
4
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Hepatic necrosis
|
phenotype |
Digestive System Diseases
|
Disease or Syndrome
|
44
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant neoplasm of gallbladder
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
425
|
81
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Adult Fibrosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
387
|
9
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
stage, non-small cell lung cancer
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
107
|
6
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Invasive carcinoma of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
473
|
21
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Acute GVH disease
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
294
|
49
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Tumor Promotion
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
170
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hyperfibrinogenemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
9
|
1
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Ischemic stroke
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1159
|
704
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Venoocclusive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
34
|
4
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Alpha thalassemia intermedia
|
disease |
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
prothrombin gene mutation
|
phenotype |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
23
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Superficial Thrombophlebitis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Attention deficit hyperactivity disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
842
|
420
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
TNF receptor-associated periodic fever syndrome (TRAPS)
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
90
|
33
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Vegetation
|
disease |
|
Anatomical Abnormality
|
67
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Reflex Epilepsy, Audiogenic
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
31
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hyperuricemia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
196
|
76
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Tumor Initiation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
533
|
8
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cervix carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1881
|
283
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Severe Sepsis
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
181
|
29
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |